【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Prosthetic Heart Valves Overview 17
3 Products under Development 18
3.1 Prosthetic Heart Valves – Pipeline Products by Stage of Development 18
3.2 Prosthetic Heart Valves – Pipeline Products by Segment 19
3.3 Prosthetic Heart Valves – Pipeline Products by Territory 20
3.4 Prosthetic Heart Valves – Pipeline Products by Regulatory Path 21
3.5 Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 22
3.6 Prosthetic Heart Valves – Ongoing Clinical Trials 23
4 Prosthetic Heart Valves – Pipeline Products under Development by Companies 24
4.1 Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 24
4.2 Prosthetic Heart Valves – Pipeline Products by Stage of Development 27
5 Prosthetic Heart Valves Companies and Product Overview 31
5.1 Aegis Surgical Limited Company Overview 31
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AorTech International plc Company Overview 32
5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Apica Cardiovascular Limited Company Overview 34
5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Children’s Hospital Company Overview 35
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 Boston Scientific Corporation Company Overview 37
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Braile Biomedica Ltda. Company Overview 46
5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Caisson Interventional, LLC Company Overview 48
5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Cardiac Dimensions, Inc. Company Overview 49
5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 CardiAQ Valve Technologies, Inc. Company Overview 53
5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Cardio3 BioSciences SA Company Overview 59
5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cephea Valve Technologies, Inc. Company Overview 60
5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Clemson University Company Overview 61
5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Colibri Heart Valve, LLC Company Overview 62
5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 CorMatrix Cardiovascular, Inc. Company Overview 70
5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CryoLife, Inc. Company Overview 75
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.16 Cytograft Tissue Engineering, Inc. Company Overview 77
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 Direct Flow Medical, Inc. Company Overview 78
5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Dura Biotech Company Overview 83
5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 Edwards Lifesciences Corporation Company Overview 85
5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.20 Emory University Company Overview 106
5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106
5.21 HighLife SAS Company Overview 108
5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.22 HLT, Inc. Company Overview 109
5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.23 Innovia LLC Company Overview 112
5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.24 JenaValve Technology GmbH Company Overview 115
5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
5.25 Leman Cardiovascular Company Overview 120
5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120
5.26 Mayo Clinic Company Overview 121
5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
5.27 Medi-Line S.A. Company Overview 122
5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.28 Medtronic plc Company Overview 123
5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123
5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135
5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.30 Micro Interventional Devices, Inc. Company Overview 136
5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.31 MicroPort Scientific Corporation Company Overview 138
5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138
5.32 Mitralix Ltd. Company Overview 142
5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.33 MitrAssist Ltd. Company Overview 143
5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143
5.34 Mitricares Company Overview 144
5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 NaviGate Cardiac Structures, Inc. Company Overview 145
5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 Neovasc Inc. Company Overview 146
5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Peca Labs, Inc. Company Overview 150
5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.38 PolyNova Cardiovascular LLC Company Overview 151
5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.39 RegenaGraft Company Overview 152
5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Revivicor, Inc. Company Overview 153
5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 SAS Cormove Company Overview 154
5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154
5.42 Scientific and Production Center Amphion, LLC Company Overview 155
5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.43 Sorin S.p.A. Company Overview 156
5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160
5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.45 St. Jude Medical, Inc. Company Overview 162
5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.46 Stellenbosch University Company Overview 175
5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175
5.47 Strait Access Technologies (Pty) Ltd Company Overview 176
5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.48 Symetis AG Company Overview 178
5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178
5.49 Tendyne Medical, Inc. Company Overview 184
5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.50 The Tel Aviv Sourasky Medical Center Company Overview 187
5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187
5.51 Thubrikar Aortic Valve, Inc. Company Overview 188
5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.52 Tissue Regenix Ltd Company Overview 190
5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.53 Transcatheter Technologies GmbH Company Overview 193
5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193
5.54 Twelve, Inc Company Overview 196
5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196
5.55 UMC Utrecht Holding BV Company Overview 197
5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197
5.56 University College London Company Overview 198
5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198
5.57 University of California, Irvine Company Overview 199
5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.58 University of Pennsylvania Company Overview 202
5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202
5.59 Valtech Cardio Ltd. Company Overview 204
5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204
5.60 ValveXchange, Inc. Company Overview 205
5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.61 VueKlar Cardiovascular Ltd. Company Overview 208
5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208
5.62 Xeltis AG Company Overview 210
5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210
6 Prosthetic Heart Valves- Recent Developments 211
7 Appendix 306
7.1 Methodology 306
7.2 About GlobalData 308
7.3 Contact Us 309
7.4 Disclaimer 309
【レポート販売概要】
■ タイトル：人工心臓弁の世界市場：パイプラインレビュー2015■ 英文：Prosthetic Heart Valves - Pipeline Review, 2015
■ 発行日：2015年4月28日
■ 調査会社：GlobalData
■ 商品コード：GDME0006EPD
■ 調査対象地域：グローバル
- エチレン酢酸ビニルコポリマー(EVA)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ethylene vinyl acetate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a …
- 世界のデジタル病理市場予測及び動向（～2018）The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The North American market is expected to grow at a health …
- 世界のSavory & Deli Foods市場におけるM&A動向（2014年2月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global savory & deli foods market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global savory & deli foods market throughout the month. Additionally, the report provides an ove …
- コイルドチュービング（CT）の世界市場分析：サービス別（井戸完了、井戸洗浄、掘削）、オペレーション別（循環/水除去、ポンプ、ロギング、穿孔）、用途別、セグメント予測、2014-2025The global coiled tubing (CT) market is expected to reach USD 4.9 billion by 2025, according to a new report by Grand View Research, Inc. Globally, declining oil production and increasing number of exploration & production activities are anticipated to drive the market growth in the next eight years. In addition, a shift in the trend for developing unconventional oil blocks globally, will boost th …
- VSaaS（映像監視クラウドサービス）の世界市場2017-2021About Video Surveillance as A ServiceVideo surveillance is the process of monitoring or observing the activities, behavior, or movements of an individual or a group to provide enhanced security. It is used by retail stores, government departments, hospitals, transportation and logistics companies, and law enforcement agencies to prevent criminal activities. Integration of the video surveillance so …
- テストステロン置換療法の世界市場2016-2020About Testosterone Replacement Therapy Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a …
- デジタル・トランスフォーメーションの世界市場：クラウドコンピューティング、ビックデータ、モビリティ、ソーシャルメディアEnterprises are adapting digital transformation products and services to implement better customer experience and improved operational process. Digital transformation includes the implementation of transformation in three key areas, namely customer experience, operational process, and business model. Enterprises are spending a major proportion of their revenue on the advancement of new and upgrade …
- 世界のエルシニア検査市場The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commer …
- モバイルコンテンツ管理の世界市場The mobile content management market size is expected to grow from USD 2.00 Billion in 2015 to USD 5.63 Billion in 2020, at a Compound Annual Growth Rate (CAGR) of 23.0%. The mobile content management solutions are gaining traction due to the increased need to access corporate content from portable devices at any time. Most organizations have started treating enterprise content as a vital corporat …
- オフハイウェイ電気自動車（EV）の世界市場予測（～2027年）Increase in mining and construction application and need for infrastructure development in developing countries is expected to drive the market for off-highway vehicles while increasing stringency in emission regulations to drive the demand for electric and hybrid equipmentThe off-highway electric vehicle market is projected to grow at a CAGR of 25.2% to reach USD 29.8 billion by 2027 from an esti …
- 世界主要国におけるマラリア検査市場2015The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerci …
- Ambirix（B型肝炎ワクチン）市場動向（～2022）Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related li …
- オートバイADAS（先進運転支援システム）の世界市場：ABS、ACC、TCS、その他Global Motorcycle Advanced Driver Assistance System (ADAS) Market: About this market Motorcycle advanced driver assistance system (ADAS) is specifically designed with a safe human-machine interface, which helps in enhancing the safety of the rider and the motorcycle. Technavio’s motorcycle advanced driver assistance system (ADAS) market analysis considers sales from segments including ABS, ACC, TC …
- 検査機の世界市場展望2017-20276According to Stratistics MRC, the Global Inspection Machine Market is accounted for $531.80 million in 2017 and is expected to reach $994.27 million by 2026 growing at a CAGR of 7.2% during the forecast period. The growing number of regulatory mandates in the healthcare industry to continue compliance with superior manufacturing practices, an increasing number of inspection checkpoints throughout …
- 油脂の世界市場予測（～2021年）：パーム油、大豆油、菜種油、ひまわり油、オリーブ油The fats & oils market is projected to grow at a CAGR of 4.4%, in terms of value, from 2016 to reach a projected value of USD 247.78 Billion by 2021. The market is driven by the demand from Asia-Pacific countries, particularly India, China, Malaysia, and Indonesia. Demand from the respective food sectors of these countries, which are supported by rise in living standards and population growth are …
